Your browser doesn't support javascript.
loading
Endpoints for clinical trials in ophthalmology.
Schmetterer, Leopold; Scholl, Hendrik; Garhöfer, Gerhard; Janeschitz-Kriegl, Lucas; Corvi, Federico; Sadda, SriniVas R; Medeiros, Felipe A.
Afiliación
  • Schmetterer L; Singapore Eye Research Institute, Singapore; SERI-NTU Advanced Ocular Engineering (STANCE), Singapore; Academic Clinical Program, Duke-NUS Medical School, Singapore; School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore; Department of Clinical Pharm
  • Scholl H; Institute of Molecular and Clinical Ophthalmology, Basel, Switzerland; Department of Ophthalmology, University of Basel, Basel, Switzerland.
  • Garhöfer G; Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria.
  • Janeschitz-Kriegl L; Institute of Molecular and Clinical Ophthalmology, Basel, Switzerland; Department of Ophthalmology, University of Basel, Basel, Switzerland.
  • Corvi F; Eye Clinic, Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Italy.
  • Sadda SR; Doheny Eye Institute, Los Angeles, CA, USA; Department of Ophthalmology, David Geffen School of Medicine at University of California, Los Angeles, CA, USA.
  • Medeiros FA; Vision, Imaging and Performance Laboratory, Department of Ophthalmology, Duke Eye Center, Duke University, Durham, NC, USA.
Prog Retin Eye Res ; 97: 101160, 2023 11.
Article en En | MEDLINE | ID: mdl-36599784

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oftalmología / Enfermedades de la Retina / Glaucoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Prog Retin Eye Res Asunto de la revista: OFTALMOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oftalmología / Enfermedades de la Retina / Glaucoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Prog Retin Eye Res Asunto de la revista: OFTALMOLOGIA Año: 2023 Tipo del documento: Article